Merck (MRK) Q1 Earnings: Key quarterly numbers that you need to note down

Merck (NYSE: MRK) today reported first quarter financial results for the period ended March 31, 2020. On GAAP basis, first quarter EPS was $1.26 vs. $1.12 in the first quarter of 2019. Non-GAAP EPS was $1.50, compared to $1.22 in the first quarter of 2019. Total sales increased 11% to $12.05 billion. Shares down nearly […]

$MRK April 28, 2020 1 min read

NYSE

$MRK · Earnings

“
Merck (NYSE: MRK) today reported first quarter financial results for the period ended March 31, 2020. On GAAP basis, first quarter EPS was $1.26 vs. $1.12 in the first quarter of 2019. Non-GAAP EPS was $1.50, compared to $1.22 in the first quarter of 2019. Total sales increased 11% to $12.05 billion. Shares down nearly […]
· April 28, 2020

Merck (NYSE: MRK) today reported first quarter financial results for the period ended March 31, 2020.

On GAAP basis, first quarter EPS was $1.26 vs. $1.12 in the first quarter of 2019. Non-GAAP EPS was $1.50, compared to $1.22 in the first quarter of 2019.

Total sales increased 11% to $12.05 billion.

Shares down nearly 2% during the pre-market hours following the earnings announcement.

In this challenging and unprecedented time, the quality of our first-quarter performance reflects strong demand for our portfolio of innovative products, continued commercial and clinical execution and the dedication and resilience of our employees around the world. The fundamentals of our business remain strong.

Kenneth C. Frazier, Chairman and CEO

You may also like:

MRK Q4 2019 Earnings AlphaGraph

MRK Q1 2019 Earnings AlphaGraph

Related Articles

Koger Q4 Earnings Preview: E-commerce push and private labels in focus

BrightSpring Health Services Q4 FY25 earnings jump on strong revenue growth

Agilent Q1 Revenue Rises 7%, Net Income Declines